Year: 2010
Resolution Number: 100
Action Taken: Approved as Amended
Status:
Author(s): Patrick J. Droste, MD
Sponsor: Domenic R. Federico, MD
On behalf of: Kent County Delegation
Committee: E (Science & Education Affairs)
Resolved Section(s):
RESOLVED: That the Michigan Delegation to the AMA ask the AMA to oppose the FDA’s rigid schedule of vision testing for patients with Vigabatrin, but to favor instead a recommendation that physicians prescribing Vigabatrin arrange follow-up testing of vision as clinically appropriate. RATIONALE: The Committee heard conflicting testimony regarding the mandatory ophthalmologic testing for patients on Vigabatrin. This was considered as a friendly amendment by the author of the resolution.
RESOLVED: That the Michigan Delegation to the AMA ask the AMA to oppose the FDA’s rigid schedule of vision testing for patients with Vigabatrin, but to favor instead a recommendation that physicians prescribing Vigabatrin arrange follow-up testing of vision as clinically appropriate. RATIONALE: The Committee heard conflicting testimony regarding the mandatory ophthalmologic testing for patients on Vigabatrin. This was considered as a friendly amendment by the author of the resolution.
Fiscal Note: NULL
Resolution: View PDF for Mandatory Electophysiologic Testing for Patients Taking Vigabatrin (SabrilTM)